Evolution of pulmonary embolism: 1 year of follow-up

C. Ribas, G. Bardi, G. Palmiero, M. Gherardi, L. Marconi, N. Carpenè, C. Manta, M. Digiorgio, A. Palla (Pisa, Italy)

Source: Annual Congress 2006 - Pulmonary hypertension: thromo-embolic processes
Session: Pulmonary hypertension: thromo-embolic processes
Session type: Thematic Poster Session
Number: 2365
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

Aims: To evaluate the evolution of pulmonary embolism (PE) in the first year of follow-up as it concerns the efficacy and complications of therapy. Methods: In the last 4 years, 522 patients had the diagnosis of PE by spiral CT scan (382, 73.2 %), pulmonary angiography (4, 0.76 %), or highly compatible perfusion lung scan (PLS) and clinical probability (136, 26 %). Then, they were followed for 1 year through clinical assesment, blood gas analysis, PLS (7, 30, 365 days after PE). PLS was quantified by the number of unperfused lung segments (Perfusion Damage Score, PDS). Moreover, in a subset of 53 patients, with EKG signs of right ventricle overload, echocardiogram was also performed at the embolization and 365 days later. Results: Seven clinical and scintigraphic relapses of PE were observed; of them 1 died during the first week, 2 during the first month. One case of major and 14 of minor bleedings were recorded. After 1 year, dyspnoea significantly decreased and PaO2 significantly improved (p<0.001). The PDS decreased significantly after 7 and between 7 and 30 days (p<0.001), not significantly between 30 and 365 days. sPAP measured on echo was normal in 8 cases, it decreased significantly in 13 cases (p<0.05) and remained almost unchanged in 32 cases after 365 days. In these latter patients the PDS was significantly higher (p<0.05) than in the remaining patients at the end of follow-up. Conclusions: A complete recovery of pulmonary perfusion was not obtained in several patients after the acute episode of PE. Patients who do not improve pulmonary hypertension at the end of follow-up recover less than the remainders.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Ribas, G. Bardi, G. Palmiero, M. Gherardi, L. Marconi, N. Carpenè, C. Manta, M. Digiorgio, A. Palla (Pisa, Italy). Evolution of pulmonary embolism: 1 year of follow-up. Eur Respir J 2006; 28: Suppl. 50, 2365

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

1 year clinical follow-up of patients affected by acute pulmonary embolism (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

Results of a dedicated service for pulmonary embolism (PE): 1 year follow up
Source: Eur Respir J 2004; 24: Suppl. 48, 560s
Year: 2004

Long term prognosis of pulmonary embolism: a two year follow-up from the master registry
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH?
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Results of dynamic follow-up of patients after idiopathic pulmonary embolism (PE)
Source: Eur Respir J 2006; 28: Suppl. 50, 47s
Year: 2006

Duration of treatment in acute pulmonary embolism: time for a change?
Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Year: 2017


Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021

Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




Fibrinolysis for pulmonary embolism, a thirteen-year experience
Source: Eur Respir J 2006; 28: Suppl. 50, 631s
Year: 2006

Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Lost in translation: Does radiological evidence of right ventricular strain in acute pulmonary embolism trigger echocardiographic follow-up?
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017

Pulmonary embolism and pulmonary hypertension - is our follow up adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

Late Breaking Abstract - An evaluation of standard UK pulmonary rehabilitation post pulmonary embolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018




Pulmonary perfusion scan follow-up in patients with acute pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Pulmonary thromboembolism in HIV (+) patients under 50 years old: a six year study
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008


Surgical treatment of pulmonary aspergilloma: 30- year experience
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001